Literature DB >> 8794431

Prevalence of genitourinary and other climacteric symptoms in 61-year-old women.

A Stenberg1, G Heimer, U Ulmsten, S Cnattingius.   

Abstract

In a population-based cohort study, 1280 women, aged 61, were interviewed regarding their genitourinary and other postmenopausal symptoms by means of an anonymous questionnaire. The group selected was to constitute all women of 61 years of age living in Uppsala county, Sweden. The response rate was 84%. All were postmenopausal women. Seventy-three percent of the women answering admitted some degree of urinary incontinence and 33% more severe degree. Forty-nine percent reported some degree of stress incontinence, 25% a more severe degree. Thirty-one percent experienced urge incontinence, 14% severely. A minority (4%), had had more than two urinary infections during the last year. The majority (67%) had changed urinating habits, going to the toilet at night and a minority complained of increased frequency of micturation (8%). Of the participating women, 59% were still sexually active, 43% had trouble with vaginal dryness and 10% with vaginal burning. Vasomotor problems such as hot flushes (30%), daily (33%) and nightly sweating (36%) were all common troubles. Forty-seven percent of the women had asked for medical help for estrogen deficiency problems, 82% were satisfied with the help they had received. Thirty-four percent were on estrogen therapy, 16% had systemic therapy 18% low dose estrogen treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794431     DOI: 10.1016/0378-5122(95)00996-5

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  11 in total

1.  Urinary Tract Infection in Postmenopausal Women.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Postural activity of the pelvic floor muscles is delayed during rapid arm movements in women with stress urinary incontinence.

Authors:  Michelle D Smith; Michel W Coppieters; Paul W Hodges
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-12-01

3.  Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women.

Authors:  Raimundo Vieira de Oliveira Filho; Natalícia de Jesus Antunes; Jaime de Oliveira Ilha; Ronilson Agnaldo Moreno; Ralph-Steven Wedemeyer; André Warnke; Gilberto De Nucci
Journal:  Br J Clin Pharmacol       Date:  2018-12-25       Impact factor: 4.335

4.  Quality of life among postmenopausal women enrolled in the Minnesota Green Tea Trial.

Authors:  Allison Dostal Webster; Deborah A Finstad; Mindy S Kurzer; Carolyn J Torkelson
Journal:  Maturitas       Date:  2017-11-02       Impact factor: 4.342

Review 5.  Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.

Authors:  David F Archer
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

6.  Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials.

Authors:  Margery Gass; Joseph Larson; Barbara Cochrane; JoAnn E Manson; Dorothy Lane; Vanessa Barnabei; Judith Ockene; Marcia L Stefanick; Charles Mouton
Journal:  Menopause       Date:  2018-03       Impact factor: 2.953

7.  Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors.

Authors:  Alison J Huang; Elya E Moore; Edward J Boyko; Delia Scholes; Feng Lin; Eric Vittinghoff; Stephan D Fihn
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

8.  Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.

Authors:  Ginger D Constantine; Shelli Graham; Cathy Clerinx; Brian A Bernick; Mitchell Krassan; Sebastian Mirkin; Heather Currie
Journal:  Post Reprod Health       Date:  2016-02-18

9.  Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.

Authors:  Sukanya Jaroenporn; Nontakorn Urasopon; Gen Watanabe; Suchinda Malaivijitnond
Journal:  J Reprod Dev       Date:  2014-04-21       Impact factor: 2.214

10.  A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.

Authors:  James H Pickar; Julia M Amadio; John M Hill; Brian A Bernick; Sebastian Mirkin
Journal:  Menopause       Date:  2016-05       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.